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FSGS lesions in IgA nephropathy
To the Editor: The interesting and detailed morphological
assessments of injury in immunoglobulin A (IgA) nephro-
pathy reported by El Karoui et al.1 describe the frequent
presence of focal segmental glomerulosclerosis (FSGS) lesions
in patients with IgA nephropathy. A remarkably high number
of their adult patients, 101 of the total 128, had lesions termed
‘consistent with FSGS’, classiﬁed by this group as hyalinosis
and collapsing glomerulopathy. The authors invoke the
Columbia classiﬁcation of FSGS in making these distinctions.
The authors use the term ‘capillary collapse and obliteration’,
but the illustrations provided (their Figure 1) show instead
that the capillaries are solidiﬁed by excess matrix without the
characteristic implosion or retracted appearance typical of
idiopathic collapsing glomerulopathy as originally described
and as seen in a similar morphological form in HIV-
associated nephropathy. The interesting glomerular epithelial
cell proliferation is not, by application of the criteria proposed
in the Columbia classiﬁcation, sufﬁcient to classify these as
typical collapsing lesions.2 We propose that the authors
emphasize the poor prognosis of this aggressive sclerosing
lesion characterized by epithelial cell proliferation without
implosion of the capillary tuft, and not confound the already
complex terminology by attempting to ﬁt this into the
collapsing glomerulopathy category of the Columbia classi-
ﬁcation. To apply the collapsing terminology to these lesions
also implies that they are likely to share similar pathogenetic
mechanisms, which remains to be proven. The observation
that these lesions are linked to a poor prognosis is important,
and distinct recognition and terminology is their due. Perhaps
‘active proliferative sclerosis’ or ‘sclerosis with epithelial
reactivity’ would come closest to capturing the essence of
the lesions as described.
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The Authors Reply: We agree completely with the observa-
tion of Fogo et al.1 that the shrunken capillary loops in the
collapsing glomerulopathy of immunoglobulin A nephro-
pathy (IgAN) more frequently have the appearance of being
obliterated by extracellular matrix than by adhesion of
capillary walls, a difference perhaps related to adjacent
mesangial deposits. In this respect, our lesion does not
completely correspond to the appearance of collapsing
glomerulopathy, as carefully deﬁned in primary focal
segmental glomerulosclerosis (FSGS).2
In effect, the authors are waging a battle similar to that
waged years ago by the makers of Xerox and Frigidaire to
preserve the sanctity of a brand name. However, as then, this
battle has already largely been lost. The term has now been
employed with varying ﬁdelity in 20 different conditions
(including IgAN in an article3 cosigned by one of the authors
of the above letter1). Collapsing glomerulopathy has thus been
degraded from a speciﬁcally deﬁned entity to a more generic
term, often of dubious validity.
We prefer to retain the term collapsing glomerulopathy in
IgAN, emphasizing the similarities with the lesion as
classically deﬁned: (1) presence in a setting of clearcut
FSGS; (2) shriveling of the glomerular tuft with near-total
obliteration of capillary lumina; (3) marked halo-like
proliferation of the overlying epithelium (identical immuno-
histochemically4 to that in primary FSGS and HIV-associated
nephropathy); (4) rapid progression to end-stage renal
disease. For us, it comes closer to the original description
than many of the entities currently parading as ‘collapsing
glomerulopathy’.
That being the case, we feel it would be counterproductive
to substitute an entirely new designation of the sort that the
authors suggest. However, it would be reasonable to add the
modiﬁer ‘IgA-associated’ to acknowledge the deﬁnite differ-
ences between the original and the copy.
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Biofilm eradication in
catheter-related infection
in dialysis patients
To the Editor: Lok and Mokrzycki1 have to be congratulated
for their excellent review article on the prevention and
management of catheter-related infection/bacteremia (CRB)
in hemodialysis (HD) patients. They discuss extensively the
pathogenesis of CRB and both the role of catheter coloniza-
tion and bioﬁlm production by microorganisms. Indeed,
bioﬁlm production prevents antibiotic penetration and action,
further sustaining release of microorganisms. The authors
also review different prophylactic antimicrobial locking
solutions, both antibiotic and non-antibiotic, of which some
have been shown to prevent or eradicate bioﬁlm formation.1
In peritoneal dialysis (PD) patients, bioﬁlm formation due
to coagulase-negative Staphylococcus (CoNS) has also been
associated with persisting asymptomatic peritonitis (deﬁned
as a peritonitis episode treated with vancomycin, with
signiﬁcant clinical improvement within 48 h and dialysate
clearing, but with persisting positive dialysate cultures).2 The
use of intraperitoneal urokinase (100,000 units), a plasmino-
gen activator, and oral rifampicin in addition to intravenous
vancomyin in these patients may lead to peritonitis resolution
with sterilization of the dialysate in up to 64% of the cases,
therefore avoiding catheter removal and interim hemo-
dialysis.2 High-dose urokinase probably allowed the
dissolution of bioﬁlm lining the PD catheter, permitting
thereafter a better action of rifampicin and vancomycin. Such
approach merits prospective testing in both HD and PD
patients with mild catheter-related infection, and probable
bioﬁlm formation, in relation to indolent microorganisms
such as CoNS.
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